↓ Skip to main content

INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian…

Overview of attention for article published in BMC Cancer, February 2023
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
21 Mendeley